Karen A Kalinyak MD
Professor, Pediatrics, University of Cincinnati College of Medicine
Join to View Full Profile
3333 Burnet AveMl 7015Cincinnati, OH 45229
Phone+1 513-636-4266
Fax+1 513-636-3549
Dr. Kalinyak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1981 - 1983
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1979 - 1981- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1977 - 1979
Lewis Katz School of Medicine at Temple UniversityClass of 1977
Certifications & Licensure
OH State Medical License 1979 - 2021
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Penicillin Prophylaxis in Sickle Cell Disease (PROPS) Start of enrollment: 1983 Aug 01
- Dipyridamole/Magnesium To Improve Sickle Cell Hydration Start of enrollment: 2005 May 01
- Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence Start of enrollment: 2005 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsAssociation between hospital admissions and healthcare provider communication for individuals with sickle cell disease.Robert M. Cronin, Manshu Yang, Jane S. Hankins, Jeannie Byrd, Brandi Pernell
Hematology. 2020-06-18 - 49 citationsRisk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey studyRobert M. Cronin, Jane S. Hankins, Jeannie Byrd, Brandi Pernell, Adetola A. Kassim
Hematology. 2019-12-01 - 21 citationsModifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease.Robert M. Cronin, Jane S. Hankins, Jeannie Byrd, Brandi Pernell, Adetola A. Kassim
Hematology. 2018-03-29
Grant Support
- Clinical CoreNational Heart, Lung, And Blood Institute2010–2011
- Clinical Trial: Neuropsychological Dysfunction/Neuroimaging Abnormalities In AduNational Center For Research Resources2008
- Dipyridamole/Magnesium To Improve Sickle Cell HydrationNational Center For Research Resources2007
- Dipyridamole/Magnesium To Improve Sickle Cell HydrationNational Heart, Lung, And Blood Institute2003–2007
- Core--ClinicalNational Heart, Lung, And Blood Institute2003–2007
- Management Of Sickle Cell Vaso-0cclusive EpisodesNational Heart, Lung, And Blood Institute1998–2002
- Core--Pediatric Sickle Cell ProgramNational Heart, Lung, And Blood Institute1998–2002
- Oxygenation And Hemoglobin Saturation During Sleep In Sickle Cell DiseaseNational Heart, Lung, And Blood Institute1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
